Previous 10 | Next 10 |
home / stock / gvdny / gvdny news
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-19 06:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...
2024-03-22 08:43:52 ET More on Givaudan SA Givaudan: Quality F&F Player, Pricey Valuation Givaudan: Exceptional Yet It Remains Priced Beyond Reach Givaudan SA (GVDBF) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Givaudan SA ...
2024-03-22 04:03:34 ET Summary DSM-Firmenich reports underwhelming results in the challenging vitamin market and plans to separate Animal Nutrition & Health business in 2025. The company continues to invest heavily in R&D, with recent breakthroughs including the creation o...
2024-03-15 10:05:53 ET Summary Givaudan continues to deliver solid results. FY2023 sales up 4.1% on an LFL basis and gross margins improve. Positive medium-term growth outlook as Givaudan's innovation efforts could help the company outpace overall industry growth. Productivity...
2024-02-13 07:21:19 ET Summary Givaudan reported solid 2023 results, with total sales declining 2.8% but showing healthy growth on a like-for-like basis. The Fragrance & Beauty segment performed well, while the Taste & Well-being segment was weaker. Givaudan operates i...
2024-01-25 15:02:07 ET Givaudan SA (GVDBF) Q4 2023 Earnings Conference Call January 25, 2024 9:00 AM ET Company Participants Gilles Andrier - Chief Executive Officer Tom Hallam - Chief Financial Officer Conference Call Participants Celine Pannuti - JPMorg...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
Givaudan SA ADR (GVDNY) is expected to report for Q4 2023
2023-12-21 10:27:09 ET Summary Novozymes and Chr. Hansen are close to completing their merger, creating a global bio-solutions leader with strong competitive moats. The combined company is expected to deliver higher revenue growth and increased profitability through cost and reven...
News, Short Squeeze, Breakout and More Instantly...
Givaudan AG ADR Company Name:
GVDNY Stock Symbol:
OTCMKTS Market:
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Usinas Siderurgicas De Minas Gerais S.A. ADR (Representing Pref Share Cl A) (USNZY) is expected to report $0 for Q2 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Senstar Technologie...
Verbund AG ADR (OEZVY) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-6.56 for Q1 2025 Johnson Matthey plc ADR (JMPLY) is expected to report for Q4 2024 RVL Pharmaceuticals plc (RVLPQ) is expected to report for Q1 2024 Ciena Corporation (CIEN...